NCT05067192View on ClinicalTrials.gov

Optimization of Morphomer-based Alpha-synuclein PET Tracers

CompletedOBSERVATIONAL

Enrollment

12

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions

Parkinson DiseaseDementia With Lewy BodiesMultiple System AtrophyCorticobasal DegenerationProgressive Supranuclear Palsy

Trial Locations (1)

22185

Skåne University Hospital, Dept of Neurology, Lund

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AC Immune SA

INDUSTRY

lead

Skane University Hospital

OTHER